To evaluate the effects of transfusions in patients with severe sepsis and septic shock on mortality.
A nemia is a very common problem in critically ill patients admitted to intensive care units (ICUs) (1) and is associated with considerable morbidity and worse outcome (2, 3) . However, several studies have indicated a potential association between blood transfusion and poor outcome from critical illness (4) (5) (6) . A randomized controlled trial by the Canadian Critical Care Trials Group comparing restrictive (target hemoglobin level, 7-9 g/dL) and liberal (target level, 10-12 g/dL) red blood cell (RBC) transfusion strategies demonstrated that a liberal strategy transfusion resulted in higher hospital mortality in younger (age <55 yrs) and less sick (Acute Physiology and Chronic Health Evaluation II [APACHE II] score ≤20) patients (4) . More recently, large observational cohort studies on blood transfusion in critically ill patients in Europe (5) and United States (6) reported that blood transfusion was independently associated with an increased risk of death. These results have had a definite influence on ICU practice and have justified the acceptance of lower hemoglobin (Hb) levels (e.g., 7 g/dL) in hemodynamically stable and nonbleeding patients.
Among the many causes of anemia in the critically ill, one of the most important is sepsis (7) . Patients with sepsis are at risk of inadequate oxygen delivery to tissues. RBC transfusions are utilized to treat anemia as well as to improve oxygen delivery to tissues. Although RBC transfusion in septic and other critically ill patients does not help increase oxygenation deficits in organ systems (8) , implementation of a therapeutic protocol that included RBC transfusion to obtain a hematocrit >30% was associated with a significant reduction in hospital mortality in the early resuscitation of patients with severe sepsis (9) . Therefore, the effects of RBC transfusions need to be reassessed in patients with severe sepsis and septic shock.
In this prospective, multicenter observational study to evaluate the effects of transfusions in patients with severe sepsis and septic shock on mortality, we analyzed the database from the Korean Sepsis Registry System, with the aim of evaluating the clinical characteristics and outcome of severe sepsis in Korean patients.
MATERIALS AND METHODS
Study Design and Setting. The Korean Sepsis Registry System study was a prospective, multicenter observational study to evaluate the clinical characteristics and outcome of community-acquired severe sepsis and septic shock from April 2005 to February 2009. The 12 university hospitals with medical (n = 12) and surgical (n = 10) ICUs were invited and voluntarily agreed to participate.
The subjects included all adult patients (≥18 yrs) who had severe sepsis or septic shock within 24 hrs of entry to the emergency room or ICU of a participating center during the study period, and were enrolled through the Korean Sepsis Registry System. Patients were followed up until death or hospital discharge. Patients who were readmitted and had been included on their first admission were not included for a second time.
Institutional Review Board approval from each participating hospitals was obtained. Because this observational study required no deviation from routine medical practice, informed consent was waived.
Definitions. Infection was defined as microbiologically documented according to the standard definitions of the United States Centers for Disease Control and Prevention (10) and/or clinically suspected infection, plus the administration of antibiotics. Sepsis and sepsis-related conditions were diagnosed in accordance with (11) . Definition of severe sepsis was the presence of sepsis plus at least one organ or system dysfunction. The criteria for acute organ or system dysfunction were modified from previous criteria (12) (see Supplemental Table S1 , Supplemental Digital Content 1, http://links. lww.com/CCM/A499). Community-acquired severe sepsis was defined as the presence of severe sepsis within 24 hrs of entry to the emergency room or ICU, and excluded nosocomial infections as defined elsewhere (10, 13) . Data Collection and Management. All data were collected using standardized webbased case report forms by the physicians or research nurses in each hospital. A coordinating center (Korea University Anam Hospital) supported data registration at each center, and all data were checked to be within acceptable ranges. Data collection at admission included demographic data and presence of underlying comorbidity determined by the Charlson's index score (14) . Clinical and laboratory data to enable the APACHE II score (15) and Sequential Organ Failure Assessment score (16) were collected, as were microbiological and clinical infectious data. RBC transfusion was recorded during ICU stay and was not collected following discharge from the ICU. There were no common indications of transfusion in participating centers. At the time of this study, the use of leukodepleted blood in participating institutions was variable.
Statistical Analyses. Data were analyzed using SAS version 9.1 (SAS Institute, Cary, NC), SPSS version 12.0 for Windows (SPSS, Chicago, IL), and MedCalc version 12.1.3.0 (MedCalc Software, Mariakerke, Belgium). The Kolmogorov-Smirnov test was used to verify the normality of distribution of continuous variables. Difference testing of group was the chi-square test, Fisher's exact test, two-tailed t test, and Mann-Whitney test. Descriptive statistics were used included mean ± sd, median (25% to 75% interquartile range [IQR]), and proportion.
The propensity scores were presently calculated using multivariate logistic regression with the SAS Proc LOGISTIC procedure. The single score (between 0 and 1) then represented the relationship between multiple characteristics and a blood transfusion status as the dependent variables. The propensity score was calculated as the probability of receiving a blood transfusion. A greedy algorithm was used to match individual patients who received a blood transfusion with individual patients who did not. The best matching was identical to the SAS greedy five digits match Macro. This meant that the blood transfusion group was first matched to nontransfusion group on five digits of the propensity score. For those that did not match, this process continued down to a one-digit match in propensity score for those that remained unmatched.
To determine the hazard ratio of mortality, we performed a multivariable Cox proportional hazard model in the overall population and the matched patients. Variables considered for the Cox regression analysis included age, sex, comorbid diseases, source of infection, Sequential Organ Failure Assessment and APACHE II scores at admission, Hb concentration at admission, type of organ dysfunction, mechanical ventilation, continuous renal replacement therapy, and RBC transfusion. The time-dependent covariate model was used to check the proportional hazard assumption of the model. Furthermore, the extended Cox model was constructed including the term of time-dependent variables, that is, time × covariates in the whole population and in the propensity-matched groups. All statistics were two-tailed, and a p value <.05 was considered significant. Table 2) .
RESULTS

From
Propensity Score-Matched CaseControl Study. One hundred fifty-two pairs were matched according to the propensity score. Detailed multivariate logistic regression model to calculate propensity scores to be transfused and receiver operating characteristics curve are available in the supplemental data (see Supplemental Table S2 and Supplemental Fig. S1 , Supplemen tal Digital Content 1, http://links.lww.com/CCM/ A499). Transfused patients for whom propensity score-matched pairs were available were older, had lower Hb level, lower Charlson's index score, lower Sequential Organ Failure Assessment score and lower APACHE II score at admission, and had lower mortality rates than those for whom no matched pairs were found (n = 255; see Supplemental Table S3 , Supplemental Digital Content 1, http://links. lww.com/CCM/A499).
There were no differences in baseline characteristics, severity scores, prevalence of severe sepsis, and invasive procedures during care of patients between the propensity score-matched patients (Table 3 ). Blood transfusion (vs. nontransfusion) was associated with lower risk of 7-day (9.2% vs. 27.0%; p < . 001 Figure 1 illustrates the cumulative hazard rates of in-hospital mortality for the transfused and nontransfused patients. There was a lower cumulative hazard of inhospital mortality in the transfused group compared with the nontransfused group in the total study population and propensity-matched patients (in the total study population, HR 0.51, 95% CI 0.39-0.69, p < .001; in propensity-matched patients, HR 0.35, 95% CI 0.23-0.53, p < .001).
DISCUSSION
In this large observational study of patients with community-acquired severe sepsis and septic shock, RBC transfusion was common (up to 39% of patients during their management in ICUs), and patients who received RBC transfusion had higher 28-day and in-hospital mortality rates than those who did not. However, after adjusting for possible confounding factors and severity of illness using a propensity score matching and extended Cox regression model, RBC transfusion was associated with lower risk of 7-day, 28-day, and in-hospital mortality.
The overall transfusion rate in the ICUs in our study was comparable to previous studies that reported rates of approximately 40% among ICU patients (5, 6) . The landmark study-the transfusion requirements in critical care trial-suggested that a Hb level as low as 7 g/dL may be adequate in a majority of critically ill patients (4, 17, 18) . Similarly, the results of the two observational cohort studies-the Anemia and Blood Transfusion in Critical Care (ABC) study and Anemia and Blood Transfusion in the Critically Ill study-support the view that blood transfusion increases the risk of death in ICU patients (5, 6). Our results of decreased mortality in transfused group of ICU patients with severe sepsis and septic shock support the recent results from the Sepsis Occurrence in Acutely Ill Patients (SOAP) study in which blood transfusion was associated with a lower risk of death within 30 days of ICU patients in extended Cox proportional hazard analysis (19) , and those of Sakr et al (20) , in which higher Hb concentrations and blood transfusions were independently associated with a lower risk of in-hospital death.
The nature of discrepancy between the results of previous observation studies (5, 6 ) and those of the recent three studies-the SOAP study, the study by Sakr, and ours-is unclear. The authors of the SOAP study speculated that the implementation of leukodepleted blood transfusion may be related to the different results by comparison to the ABC study, which used very similar study protocols to the SOAP study (19) . Leukodepleted blood, which may reduce some of the negative immunosuppressive effects of transfusions, was much more commonly used in the SOAP study compared to the ABC study (19) . The leukoreduction was also implemented in the single-center cohort study of Sakr et al (20) . However, in our study, implementation of leukodepleted blood was minimal (15% [48/325] of transfused patients for whom information on leukodepletion was available) because leukodepleted blood transfusion for patients with sepsis is not yet covered by health insurance in Korea. Therefore, we do not believe that implementation of leukodepleted blood could have influenced the decreased mortality in our study.
We speculate that the differences in proportion of patients with sepsis may account for the different results between the SOAP and ABC studies. In the SOAP study, the proportion of severe sepsis and septic shock were 37.4% (1177/3147) (21), whereas sepsis was listed as the primary diagnosis in 3.3% (115/3534) of patients in the ABC study (5) . In our study, all patients had been diagnosed with severe sepsis or septic shock. Hence, differences were likely due to differences in the proportion of patients with sepsis per se. This speculation may support the results of Sakr et al (20) , in which blood transfusions were independently associated with a lower risk of in-hospital death in patients with severe sepsis in a subgroup analysis.
Another possible explanation is that Hb thresholds for transfusions have decreased over time following the results of the landmark study by Hébert et al (4): clinicians have revised their strategies. The Society of Critical Care Medicine practice parameters for hemodynamic support of sepsis in adult patients (2004 update) recommended that Hb concentration should be maintained >8-10 g/dL (22) . Recently, the evidence-based Surviving Sepsis Guidelines 2008 recommended more liberal blood transfusion to achieve oxygen saturation of 70% in central venous blood during the first 6 hrs of resuscitation than the transfusion requirements in critical care trial and both observational studies-the ABC study, and Anemia and Blood Transfusion in the critically ill study (5, 23) . In our study, the mean pretransfusion Hb (7.7 g/dL) was consistent with recent recommendations, but was lower than those (about 8.5 g/dL) of the ABC and Anemia and Blood Transfusion in the Critically Ill studies. Therefore, transfusion thresholds may have become so low that the benefits of blood transfusion outweigh the risks. To our knowledge, this study is the largest to date investigating the impact of blood transfusion in patients with community-acquired severe sepsis and septic shock. However, some limitations should be considered. First, the study was observational in design. Other factors not included in this analysis associated with both transfusions and improved survival might explain the improved survival rates. Although the analysis attempted to control for confounding factors by using propensity matching, it was limited only to the factors recorded. Second, the indication for blood transfusion and data for tissue oxygenation before and after blood transfusion were not considered in our analysis and may have been important confounding factors. Third, storage time of the transfused blood was not evaluated. Some studies found associations between the age of transfused blood and poorer outcomes, whereas others did not (24) . Fourth, there could be an inclusion bias because all the septic patients may not have been entered into our database because of the long study period and voluntary participation.
Most of the guidelines conclude that RBC transfusion should not be based on Hb concentration. Decision for RBC transfusion should be based on an individual patient's intravascular volume status, evidence of shock, duration and extent of anemia, and cardiopulmonary physiologic parameters (25) . Although our study was conducted in patients with severe sepsis and septic shock, our results are in line with the results of previous studies in medical and/or surgical ICUs patients-the SOAP study and the Sakr study (19, 20) . Therefore, our results may be applied to other critically ill patients pending the results of future randomized controlled trials.
In conclusion, this study suggests that blood transfusion may be associated with improved survival in patients with community-acquired severe sepsis and septic shock. Randomized controlled studies are needed to confirm the potential benefit of blood transfusion in critically ill patients including this specific population.
